Tetrahidroimidazol [1,2-a] pyrazines and tetrahidrotriazol [4,3-a] pyrazines as Dipeptidyl peptidase inhibitors useful for the Treatment or prevention of Diabetes
Merck Sharp & Dohme Corp.; (a New Jersey corporation)
发明人:
Scott D. Edmondson,Michael H. Fisher,Dooseop Kim,Malcolm Maccoss,Emma R. Parmee,Ann E. Weber,Jinyou Xu
申请号：
IS8617
公开号：
IS2964B
申请日:
2007.03.06
申请国别(地区):
IS
年份:
2017
代理人:
摘要：
The present invention is directed to pharmaceutical compositions comprising compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and the use of these compositions in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes.
